Insights Into Management of AEs in CLL
Perspectives of community physicians from Puerto Rico on optimal integration and side effect management of novel therapies
Faculty Chair
Javier Pinilla, MD, PhD
Moffitt Cancer Center, Tampa, FL
More Information
- Virtual series
REPORT SNAPSHOT
- A virtual, moderated roundtable discussion focusing on the treatment of chronic lymphocytic leukemia
- Disease state and data presentations were developed in conjunction with a national or regional oncology expert
- Insights on the following therapies were obtained: acalabrutinib, ibrutinib, zanubrutinib, obinutuzumab, rituximab, venetoclax
GEOGRAPHIC REPRESENTATION & CONTENT DEVELOPMENT
- Data collection was accomplished through use of audience response system questioning and moderated discussion
- The group of advisors comprised 10–15 medical oncologists representing Puerto Rico